UPDATE 1-J&J to exit Kenvue, a year after spinoff

(Adds details throughout)

May 13 (Reuters) – Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.

Shares of Kenvue fell nearly 4% in premarket trading.

Based on the stock’s last close, the offering would be worth about $3.75 billion, according to Reuters calculation.

(Reporting by Leroy Leo in Bengaluru; Editing by Shilpi Majumdar and Sriraj Kalluvila)

(c) Copyright Thomson Reuters 2024. Click For Restrictions – https://agency.reuters.com/en/copyright.html